Skip to content

Patent Law Weblog

    • About

recent posts

  • Amici Address Section 1498 Scope in Moderna COVID-19 Infringement Appeal: In Favor of Reversal
  • Amici Address Section 1498 Scope in Moderna COVID-19 Infringement Appeal: In Favor of Affirmance
  • Arbutus Responds to Moderna’s Appeal of District Court Infringement Judgment over COVID Vaccines
  • Moderna Appeals District Court Infringement Judgment over COVID Vaccines
  • USPTO Requires Foreign-domiciled Patent Applicants and Owners to Be Represented by USPTO-registered Practitioners

about

  • Twitter
  • Facebook
  • Instagram

Ecopia and Caprion to Merge

January 5, 2007

    By Jason Derry —

Ecopia
Ecopia BioSciences Inc. and
Caprion Pharmaceuticals Inc. have
announced the intent to merge and form a new company that will focus on oncology and infectious
disease.

Caprion
Jason Derry, Ph.D., who graduated with honors from DePaul University College of Law, is a molecular biologist and founding author of Patent Docs.

Share this:

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
Like Loading…
Posted in Biotech/Pharma Business

Leave a comment Cancel reply

←Pharmacopeia and Wyeth Reach Agreement
Elusys and Pfizer to Collaborate→

Blog at WordPress.com.

  • Comment
  • Reblog
  • Subscribe Subscribed
    • Patent Docs
    • Join 130 other subscribers
    • Already have a WordPress.com account? Log in now.
    • Patent Docs
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Copy shortlink
    • Report this content
    • View post in Reader
    • Manage subscriptions
    • Collapse this bar
%d